Ono Pharmaceutical Co (MEX:4528N) Total Equity: MXN97,349 Mil (As of Mar. 2026)


MEX:4528N Ono Pharmaceutical Co Ltd MEX:4528N
88 GF Score
Price MXN341.69
GF Value MXN324.16
! 2 Warning Signs
View Full Analysis

What is Ono Pharmaceutical Co Total Equity?

Ono Pharmaceutical Co MEX:4528N 88 Total Equity is MXN97,349 Mil as of Mar. 2026. GuruFocus rates MEX:4528N with a GF Score™ of 88/100 and a GF Value™ of MXN324.16. The stock has 2 warning signs investors should review.

Ono Pharmaceutical Co's total equity for the quarter that ended in Mar. 2026 was MXN97,349 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Ono Pharmaceutical Co Total Equity Historical Data

* Premium members only.

The historical data trend for Ono Pharmaceutical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ono Pharmaceutical Co Total Equity Chart

Ono Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 111,105.41 100,844.65 88,466.00 108,180.96 97,349.01

Ono Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 108,180.96 101,434.12 100,738.40 97,625.39 97,349.01
MEX:4528N
88GF Score
Ono Pharmaceutical Co Ltd MEX:4528N
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ono Pharmaceutical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Ono Pharmaceutical Co's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=125744.35-28395.337
=97,349

Ono Pharmaceutical Co's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=125744.35-28395.337
=97,349

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of MXN97,349 Mil mean?
Ono Pharmaceutical Co (MEX:4528N) has a Total Equity of MXN97,349 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Ono Pharmaceutical Co and its competitors.
Is Ono Pharmaceutical Co's Total Equity too high?
Ono Pharmaceutical Co's current Total Equity is MXN97,349 Mil. Overall, Ono Pharmaceutical Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Ono Pharmaceutical Co's Total Equity compare to LLY and JNJ?
Ono Pharmaceutical Co's Total Equity of MXN97,349 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Ono Pharmaceutical Co and its competitors. Ono Pharmaceutical Co's current Total Equity is MXN97,349 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ono Pharmaceutical Co stock overvalued right now?
Ono Pharmaceutical Co (MEX:4528N) has a current Total Equity of MXN97,349 Mil. The stock's GF Value™ is MXN324.16, compared to a current price of MXN341.69 — trading 5.4% above its estimated fair value. The current Total Equity is MXN97,349 Mil. Ono Pharmaceutical Co's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Ono Pharmaceutical Co (MEX:4528N), the current Total Equity is MXN97,349 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ono Pharmaceutical Co (MEX:4528N) Overvalued in 2026?

Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued. The current stock price of MXN341.69 is trading 5.4% above its estimated GF Value™ of MXN324.16.

Key valuation signals for MEX:4528N:

  • Total Equity: MXN97,349 Mil
  • GF Value™: MXN324.16 vs. price of MXN341.69 (5.4% above fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the MEX:4528N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ono Pharmaceutical Co Business Description

Address 1-8-2 Kyutarocho, Chuo-ku, Osaka, JPN, 541-8564
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
88GF Score

Get the complete analysis for MEX:4528N

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN341.69
Price
MXN324.16
GF Value